We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ajinomoto Bio-Pharma Services and Revance Therapeutics Inc. have signed a strategic commercial manufacturing agreement for the supply of DaxibotulinumtoxinA for Injection.